Depomed Trial Disappoints

Shares of Depomed (DEPO) are plunging today after its late-stage trial of the drug Serada failed ...  More »

Shares of Depomed (DEPO) are plunging today after its late-stage trial of the drug Serada failed to meet its goals. In studies including a total of 1,100 women, two doses of Serada as well as a placebo were given to treat hot flashes.  « Less